Cargando…

Positive predictive value of ERBB2 copy number gain by tissue or circulating tumor DNA next-generation sequencing across advanced cancers

Background: The correlation of ERBB2 copy number gain (CNG) from tissue or circulating tumor DNA (ctDNA) by next-generation sequencing (NGS) with standard HER2 tissue evaluation is not well understood. Materials and Methods: We retrospectively identified patients with ERBB2 CNG on commercial NGS. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shah, Ami N., Sunderraj, Ashwin, Finkelman, Brian, See, Sharlene H., Davis, Andrew A., Gerratana, Lorenzo, Wehbe, Firas, Katam, Neelima, Mahalingam, Deva, Gradishar, William J., Behdad, Amir, Blanco, Luis, Cristofanilli, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8809397/ https://www.ncbi.nlm.nih.gov/pubmed/35126865 http://dx.doi.org/10.18632/oncotarget.28188

Ejemplares similares

Landscape of circulating tumour DNA in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2020)

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2019)

Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis
por: Gerratana, Lorenzo, et al.
Publicado: (2023)

Cell-free DNA comparative analysis of the genomic landscape of first-line hormone receptor-positive metastatic breast cancer from the US and China
por: Liu, Xiaoran, et al.
Publicado: (2021)

ErbB2 copy number gain is associated with adverse outcome in canine mammary carcinoma
por: SAKAI, Kosei, et al.
Publicado: (2021)

Estimating copy number using next-generation sequencing to determine ERBB2 amplification status
por: Nakamura, Kohei, et al.
Publicado: (2021)

Genomic copy number gains of ErbB family members predict poor clinical outcomes in glioma patients
por: Liu, Rui, et al.
Publicado: (2017)

Simultaneous copy number gains of NUPR1 and ERBB2 predicting poor prognosis in early-stage breast cancer
por: Jung, Seung-Hyun, et al.
Publicado: (2012)

Outcomes of Cancer Patients with COVID-19 in a Hospital System in the Chicago Metropolitan Area
por: Mina, Alain, et al.
Publicado: (2022)

Longitudinal Dynamics of Circulating Tumor Cells and Circulating Tumor DNA for Treatment Monitoring in Metastatic Breast Cancer
por: Gerratana, Lorenzo, et al.
Publicado: (2021)

Circulating tumour DNA characterisation of invasive lobular carcinoma in patients with metastatic breast cancer
por: Davis, Andrew A., et al.
Publicado: (2022)

Detection of erbB2 copy number variations in plasma of patients with esophageal carcinoma
por: Andolfo, Immacolata, et al.
Publicado: (2011)

Mitochondrial DNA copy number instability in ERBB2-amplified breast cancer tumors
por: Ebrahimi, Elmira, et al.
Publicado: (2018)

Analysis of copy number loss of the ErbB4 receptor tyrosine kinase in glioblastoma
por: Jones, DeAnalisa C., et al.
Publicado: (2018)

pH- and Temperature-Dependent Peptide Binding to the Lactococcus lactis Oligopeptide-Binding Protein A Measured with a Fluorescence Anisotropy Assay
por: Norcross, Stevie, et al.
Publicado: (2019)

Co-incidental increase in gene copy number of ERBB2 and LRIG1 in breast cancer
por: Ljuslinder, Ingrid, et al.
Publicado: (2009)

The Landscape of Targeted Therapies in TNBC
por: Vagia, Elena, et al.
Publicado: (2020)

Phase II study of pembrolizumab and capecitabine for triple negative and hormone receptor-positive, HER2−negative endocrine-refractory metastatic breast cancer
por: Shah, Ami N, et al.
Publicado: (2020)

Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC
por: Wei, Jiacong, et al.
Publicado: (2021)

EGFR-activating mutations, DNA copy number abundance of ErbB family, and prognosis in lung adenocarcinoma
por: Chen, Hsuan-Yu, et al.
Publicado: (2016)

Evidence revealing the role of T cell regulators (Tregs) in periodontal diseases: A review
por: Ilango, Paavai, et al.
Publicado: (2021)

Unproductive Effects of ALK Gene Amplification and Copy Number Gain in Non-Small-Cell Lung Cancer. ALK Gene Amplification and Copy Gain in NSCLC
por: Zito Marino, Federica, et al.
Publicado: (2020)

Regulation of Transient Site-specific Copy Gain by MicroRNA
por: Black, Joshua C., et al.
Publicado: (2016)

Clinical impacts of genomic copy number gains at Xq28
por: Yamamoto, Toshiyuki, et al.
Publicado: (2014)

Single-Cells Isolation and Molecular Analysis: Focus on HER2-Low CTCs in Metastatic Breast Cancer
por: D’Amico, Paolo, et al.
Publicado: (2021)

Precise ERBB2 copy number assessment in breast cancer by means of molecular inversion probe array analysis
por: Christgen, Matthias, et al.
Publicado: (2016)

What next for gain-of-function research in Europe?
por: Fears, Robin, et al.
Publicado: (2015)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
por: Walch, Axel, et al.
Publicado: (2000)

KRAS and ERBB-family genetic alterations affect response to PD-1 inhibitors in metastatic nonsquamous NSCLC
por: Cinausero, Marika, et al.
Publicado: (2019)

Copy number gain of VCX, X-linked multi-copy gene, leads to cell proliferation and apoptosis during spermatogenesis
por: Ji, Juan, et al.
Publicado: (2016)

High-level gain of mesenchymal-epithelial transition factor (MET) copy number using next-generation sequencing as a predictive biomarker for MET inhibitor efficacy
por: Wu, Shibo, et al.
Publicado: (2020)

Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling
por: Wandinger, Sebastian K., et al.
Publicado: (2016)

ERBB2 Mutations as Potential Predictors for Recurrence in Colorectal Serrated Polyps by Targeted Next-Generation Sequencing
por: Wang, Qi-Wen, et al.
Publicado: (2022)

A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications
por: Marotta, Michael, et al.
Publicado: (2012)

Comprehensive Assessment of Copy Number Alterations Uncovers Recurrent AIFM3 and DLK1 Copy Gain in Medullary Thyroid Carcinoma
por: Araujo, Aline Neves, et al.
Publicado: (2021)

Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas
por: Seo, A N, et al.
Publicado: (2014)

Centromere 17 copy number gain reflects chromosomal instability in breast cancer
por: Lee, Kyoungyul, et al.
Publicado: (2019)

ERBB2 and PTPN2 gene copy numbers as prognostic factors in HER2-positive metastatic breast cancer treated with trastuzumab
por: Ellegård, Sander, et al.
Publicado: (2019)

Allele-specific copy number profiling by next-generation DNA sequencing
por: Chen, Hao, et al.
Publicado: (2015)

Structural Equation Modeling of Latent Growth Curves of Weight Gain among Treated Tuberculosis Patients
por: Vasantha, Mahalingam, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_emmvnil9q9t707n6cono4q0ira